戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 farct volume was significantly influenced by 17beta-oestradiol.
2 o that observed for ER's endogenous hormone, 17beta-oestradiol.
3 ry administration of physiological levels of 17beta-oestradiol (0.08 mg/kg/day) in vivo.
4 prague-Dawley rats were ovariectomised and a 17beta-oestradiol (0.25 mg, 21 day release) or placebo p
5                                              17beta-Oestradiol (1 microM), reported to potentiate BKC
6 pounds four of them being natural (oestriol, 17beta-oestradiol, 17alpha-oestradiol and oestrone), fou
7  that the biologically active metabolites of 17beta-oestradiol, 2-hydroxyoestradiol (2-OHE2 ) and 4-h
8 europrotective benefits previously seen with 17beta-oestradiol after spinal cord injury may be in par
9 the oxytocin precursor gene as biomarker for 17beta oestradiol and dexamethasone treatment in beef ca
10 by 33.5 and 13.3-fold in cattle treated with 17beta oestradiol and dexamethasone, respectively, in co
11 e is a valid marker for detection of illicit 17beta oestradiol and/or dexamethasone use in beef cattl
12 and 16alpha-hydroxytestosterone to oestrone, 17beta-oestradiol and 17beta,16alpha-oestriol, respectiv
13 ng mechanisms of the catecholoestradiols, to 17beta-oestradiol and catecholamines, we observed that c
14  muscle nNOS correlated directly with plasma 17beta-oestradiol and inversely with the magnitude of sy
15 ER in complex with the endogenous oestrogen, 17beta-oestradiol, and the selective antagonist raloxife
16 ng of MAPKs involved in catecholoestradiol-, 17beta-oestradiol- and catecholamine-induced endothelial
17  interaction between peptides and PDIp, with 17beta-oestradiol being the most potent inhibitor.
18 sis of this nonapeptide only in cattle after 17beta oestradiol, but not after dexamethasone or placeb
19 produced by ATP and tamoxifen was blocked by 17beta-oestradiol, but not 17alpha-oestradiol.
20 vented by chronic treatment of OVX rats with 17beta-oestradiol, but not with chronic progesterone or
21                       We also found that the 17beta-oestradiol decreased Ca(2+) retention in brain mi
22 ptide were measured in beef cattle receiving 17beta oestradiol, dexamethasone or placebo over a perio
23        We have investigated rapid effects of 17beta-oestradiol (E) on prolactin (PRL) release in vitr
24                   Myocytes were incubated +/-17beta-oestradiol (E2 = 1 nm) and INCX was measured on d
25      KEY POINTS: The catechol metabolites of 17beta-oestradiol (E2 beta), 2-hydroxyoestradiol (2-OHE2
26                                The impact of 17beta-oestradiol (E2) exposure on autonomic control of
27  we report that in human breast cancer cells 17beta-oestradiol (E2)-bound oestrogen receptor alpha (E
28                                       Plasma 17beta-oestradiol in oestradiol and placebo groups was 7
29 f the human Msx-2 homologue was regulated by 17beta-oestradiol in the MCF-7 breast cancer cell line.
30 -treatment with a high physiological dose of 17beta-oestradiol increased infarct volume after permane
31 actors which, on binding the steroid hormone 17beta-oestradiol, interacts with co-activator proteins
32                    Intranasally administered 17beta-oestradiol is significantly better than placebo;
33 ffects of allopregnanolone, progesterone and 17beta-oestradiol on oxytocin and vasopressin release fr
34                                 Furthermore, 17beta-oestradiol protected G93A cortical neurons and sp
35 utaneous implantation of a pellet containing 17beta-oestradiol (release rate 5 mg (21 days)-1).
36 s, rats were either ovariectomized and given 17beta-oestradiol replacement (OVXE2) or sham ovariectom
37                           In addition, while 17beta-oestradiol replacement at the end of the long-ter
38 nd they provide increased support that early 17beta-oestradiol replacement is critical in preventing
39                                An intranasal 17beta-oestradiol spray, S21400, which bypasses such dra
40  in vitro culture system we demonstrate that 17beta-oestradiol treatment (50 nM) is sufficient to inc
41 CA3 hypersensitivity and amyloidogenesis, if 17beta-oestradiol was initiated at the time of ovariecto
42                              However, unlike 17beta-oestradiol, which induces proliferation via oestr

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。